- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02252471
Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females
September 25, 2014 updated by: Danielle Parrish, University of Houston
This pilot study will: 1) demonstrate the feasibility of delivering CHOICES-TEEN with master's level mental health professionals within a juvenile justice setting; 2) determine acceptance of CHOICES-TEEN as measured by client adherence, retention, and treatment satisfaction; and 3) assess client improvement at 3-month follow-up (e.g., reduction of risk of HIV, nicotine-exposed pregnancy, and alcohol-exposed pregnancy).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The overall objective of this study is to assess the feasibility and promise of an adapted CHOICES preconception intervention (CHOICES-TEEN) in reducing the risk of HIV, nicotine-exposed pregnancy (NEP), and alcohol-exposed pregnancy (AEP) in adolescent females on intensive community probation.
The current study posits that a two-session CHOICES intervention adapted to target multiple bundled health risks-AEP, NEP, and HIV-will be feasible, acceptable, and promising in reducing these risks among females on community-based juvenile probation.
This study will: Aim 1: Modify the efficacious CHOICES preconception intervention to target the prevention of HIV, AEP, and NEP.
The result will be a two session individual intervention (CHOICES-TEEN) and accompanying therapy manual based on the Transtheoretical Model (TTM) and Motivational Interviewing.
Aim 2: Conduct a one-arm feasibility trial with females in the juvenile justice system to assess the promise of CHOICES-TEEN.
This pilot study will: 1) demonstrate the feasibility of delivering CHOICES-TEEN with master's level mental health professionals within a juvenile justice setting; 2) determine acceptance of CHOICES-TEEN as measured by client adherence, retention, and treatment satisfaction; and 3) assess client improvement at 3-month follow-up (e.g., reduction of risk of HIV, NEP, and AEP).
This study will inform subsequent Stage II/III behavioral intervention studies and contribute to a missing, fundamental element in the knowledge base - further understanding of the feasibility of targeting bundled health risks in high-risk adolescents, and the potential promise of a gender-specific intervention for this population.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Have had vaginal intercourse with a male in the last 90 days
- Inconsistent/ineffective contraception use
- Inconsistent/ineffective condom use
- Drinking at risk levels
- Smoking
- Available for the follow-up period
Exclusion Criteria:
- Pregnant
- Infertile
- Insufficient locator information
- Language other than English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Choices-Teen Intervention
A three session intervention with two counseling sessions with a master's level therapist and a counseling session with a physician.
The counseling with the master's level therapist utilizes a motivational interviewing approach to encourage changes in alcohol use, contraceptive use, smoking and HIV risk behaviors.
This part of the intervention (a) provides norms-based-but personalized-feedback; (b) encourages participating in the smoking cessation program; (c) increases motivation to change each of the target behaviors; (d) decreases temptation to engage in risk behaviors; (e) increases confidence to avoid risk behaviors; and (f) develops a personalized, tailored change plan.
The physician session provides individualized contraception and HIV risk reduction counseling.
|
Choices-Teen participants in this condition will receive two brief motivational-interviewing-based counseling sessions, and one counseling session with a physician.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk of alcohol-exposed pregnancy
Time Frame: 3 months
|
Timeline Followback Interview
|
3 months
|
|
Risk of nicotine-exposed pregnancy
Time Frame: 3 months
|
Timeline Followback Interview
|
3 months
|
|
HIV risk
Time Frame: 3 months
|
Timeline Followback Interview
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Excessive alcohol consumption
Time Frame: 3 months
|
AUDIT Scale
|
3 months
|
|
Psychological distress and symptoms
Time Frame: 3 months
|
Brief Symptom Inventory -18
|
3 months
|
|
Pros and cons of engaging in health risk behaviors (alcohol, smoking, HIV)
Time Frame: 3 months
|
Decisional Balance Scale
|
3 months
|
|
Experiential and behavioral processes of change for health risk behaviors (alcohol, smoking, HIV)
Time Frame: 3 months
|
Processes of Change Questionnaire
|
3 months
|
|
Temptation to engage in health risk behaviors (alcohol, smoking, HIV)
Time Frame: 3 months
|
Temptation Scale
|
3 months
|
|
Confidence/self-efficacy to not engage in health risk behaviors (alcohol, smoking, HIV)
Time Frame: 3 months
|
Confidence Scale
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Danielle E Parrish, Ph.D., University of Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
September 20, 2014
First Submitted That Met QC Criteria
September 25, 2014
First Posted (Estimate)
September 30, 2014
Study Record Updates
Last Update Posted (Estimate)
September 30, 2014
Last Update Submitted That Met QC Criteria
September 25, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R03DA034099-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University GhentActive, not recruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Virginia Polytechnic Institute and State UniversityActive, not recruitingCigarette Smoking Behavior | Smoking Behaviors | CigaretteUnited States
-
Johns Hopkins UniversityNational Center for Advancing Translational Sciences (NCATS); Community Partnership...CompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
Clinical Trials on Choices-Teen
-
Pro-Change Behavior SystemsCompletedViolence | Bullying
-
University of Texas at AustinWayne State UniversityRecruitingRisk for an Alcohol-Exposed Pregnancy | Risk for Marijuana-Exposed Pregnancy | Risk for Substance-Exposed Pregnancy | HIV Risk | Sexually Transmitted Infection RiskUnited States
-
Northeastern UniversityNational Institute of Nursing Research (NINR)CompletedRisk Behavior | HIV | Sexual Behavior | Chlamydia | Women's RoleUnited States
-
Yale UniversityCompletedObesity | Type 2 DiabetesUnited States
-
Johns Hopkins UniversityNational Institute on Aging (NIA); Medstar Health Research InstituteCompleted
-
University of PrimorskaElettra Synchrotron TriesteCompletedAsymptomatic ConditionSlovenia
-
University of FloridaNational Human Genome Research Institute (NHGRI)Active, not recruitingSickle Cell Disease | Sickle Cell TraitUnited States
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); California...UnknownObesity | Weight Loss | Weight ControlUnited States
-
University of Southern DenmarkThe Novo Nordic Foundation; Team Denmark; The Danish Sports ConfederationRecruiting